Administration, Intranasal

"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Delivery of medications through the nasal mucosa.

Descriptor ID	D000281
MeSH Number(s)	E02.319.267.120.655.500
Concept/Terms	Administration, Intranasal Administration, Intranasal Intranasal Drug Administration Drug Administration, Intranasal Intranasal Administration Administrations, Intranasal Intranasal Administrations Administration, Intranasal Drug Administrations, Intranasal Drug Drug Administrations, Intranasal Intranasal Drug Administrations Administration, Nasal Administrations, Nasal Nasal Administration Nasal Administrations

Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Topical [E02.319.267.120]
Administration, Mucosal [E02.319.267.120.655]
Administration, Intranasal [E02.319.267.120.655.500]

Below are MeSH descriptors whose meaning is related to "Administration, Intranasal".

Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.

Bar chart showing 63 publications over 28 distinct years, with a maximum of 6 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	2	2
1997	0	2	2
1998	0	1	1
2000	0	1	1
2001	0	1	1
2003	0	4	4
2004	1	0	1
2005	0	2	2
2006	0	4	4
2007	0	4	4
2008	0	6	6
2009	0	3	3
2010	0	3	3
2011	1	2	3
2012	0	2	2
2013	0	2	2
2014	0	1	1
2015	0	2	2
2016	0	2	2
2017	1	2	3
2018	0	4	4
2019	0	2	2
2020	0	2	2
2021	0	2	2
2022	0	1	1
2023	0	1	1
2024	0	1	1
2025	1	0	1

Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.

Humphrey TJL, Qian W, Chen-Xu M, Dowling F, Gatley K, Adhikari R, Hensman T, Stockley L, Bassi A, Bathla N, Dasgupta I, Dosanjh DPS, Jellings? M, S?rensen P, Jensen ML, Callesen AW, Bradley JR, Jha V, Sommer MOA, Hiemstra TF, Smith RM. Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial. BMC Infect Dis. 2025 Feb 11; 25(1):204.

View in: PubMed
Fern?ndez-Rodr?guez D, Cho J, Chisari E, Citardi MJ, Parvizi J. Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial. Sci Rep. 2024 Jul 20; 14(1):16739.

View in: PubMed
Rao AV, Stowens JC. Intranasal Fentanyl: Assessing Analgesic Modalities in the Pediatric Emergency Department. Pediatr Emerg Care. 2023 02 01; 39(2):e59.

View in: PubMed
Misra SN, Sperling MR, Rao VR, Peters JM, Davis C, Carrazana E, Rabinowicz AL. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia. 2022 10; 63(10):2684-2693.

View in: PubMed
Quinn K, Kriss S, Drapkin J, Likourezos A, Pushkar I, Brady J, Yasavolian M, Chitnis SS, Motov S, Fromm C. Analgesic Efficacy of Intranasal Ketamine Versus Intranasal Fentanyl for Moderate to Severe Pain in Children: A Prospective, Randomized, Double-Blind Study. Pediatr Emerg Care. 2021 May 01; 37(5):250-254.

View in: PubMed
Cross DJ, Huber BR, Silverman MA, Cline MM, Gill TB, Cross CG, Cook DG, Minoshima S. Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice. J Alzheimers Dis. 2021; 83(1):379-394.

View in: PubMed
Farf?n N, Carril J, Redel M, Zamorano M, Araya M, Monz?n E, Alvarado R, Contreras N, Tapia-Bustos A, Quintanilla ME, Ezquer F, Vald?s JL, Israel Y, Herrera-Marschitz M, Morales P. Intranasal Administration of Mesenchymal Stem Cell Secretome Reduces Hippocampal Oxidative Stress, Neuroinflammation and Cell Death, Improving the Behavioral Outcome Following Perinatal Asphyxia. Int J Mol Sci. 2020 Oct 21; 21(20).

View in: PubMed
Bielory L, Gross GN, Letierce A, Melas-Melt L, Lucio L. Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis. Ann Allergy Asthma Immunol. 2020 06; 124(6):616-621.e3.

View in: PubMed
Quintanilla ME, Ezquer F, Morales P, Santapau D, Berr?os-C?rcamo P, Ezquer M, Herrera-Marschitz M, Israel Y. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Res Ther. 2019 07 08; 10(1):205.

View in: PubMed
Cross DJ, Meabon JS, Cline MM, Richards TL, Stump AJ, Cross CG, Minoshima S, Banks WA, Cook DG. Paclitaxel Reduces Brain Injury from Repeated Head Trauma in Mice. J Alzheimers Dis. 2019; 67(3):859-874.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement